ClinicalTrials.Veeva

Menu

The Effect of Dexmedetomidine for Emergence Cough

A

Ajou University School of Medicine

Status

Completed

Conditions

Cough

Treatments

Drug: Normal saline
Drug: Remifentanil
Drug: Dexmedetomidine

Study type

Interventional

Funder types

Other

Identifiers

NCT03622502
AJIRB-MED-OBS-18-170

Details and patient eligibility

About

Dexmedetomidine or remifentanil are effective in attenuating cough during peri-extubation period after general anesthesia. The purpose of this study was to investigate the effect of dexmedetomidine on the remifentanil concentration for the cough suppression during anesthetic emergence.

Full description

Administration of dexmedetomidine before end of surgery could reduce airway reflexes and hemodynamic changes during tracheal extubation. Compared with remifentanil alone, administration of dexmedetomidine in combination with remifentanil is effective in relieving cough and hemodynamic changes without inhibition of respiration. The purpose of this study was to investigate the effect of dexmedetomidine on the remifentanil concentration for the cough suppression during anesthetic emergence using the modified up-and-down method.

Enrollment

48 patients

Sex

All

Ages

19 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA physical status I or II undergoing endoscopic sinus surgery or septoplasty under general anesthesia

Exclusion criteria

  • predicted difficult airway
  • body mass index > 35 kg/m2,
  • recent upper respiratory infection
  • asthma
  • current smoker
  • patients using angiotensin converting enzyme-inhibitors
  • uncontrolled hypertension

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

48 participants in 2 patient groups

Dexmedetomidine
Experimental group
Description:
Dexmedetomidine was infused before end of surgery and remifentanil was maintained at predetermined effect-site concentration during the emergence period
Treatment:
Drug: Dexmedetomidine
Drug: Remifentanil
Remifentanil
Active Comparator group
Description:
Normal saline was infused before end of surgery and remifentanil was maintained at predetermined effect-site concentration during the emergence period
Treatment:
Drug: Remifentanil
Drug: Normal saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems